The post hoc analysis of postintervention follow-up of calcium and vitamin D (CaD) supplements suggested reduced cancer mortality and increased cardiovascular disease (CVD) mortality. The multicenter trial across the US included 36 282 postmenopausal women randomized 1:1 to 1000 mg of calcium carbonate (400 mg of elemental calcium) with 400 IU of vitamin D3 daily or placebo for 7 years. For women assigned to CaD vs placebo, a 7% reduction in cancer mortality was observed with a median cumulative follow-up of 22.3 years (1817 vs. 1943 deaths; hazard ratio [HR], 0.93), along with a 6% increase in CVD mortality (2621 vs. 2420 deaths; HR, 1.06). There was no effect on all-cause mortality (7834 vs. 7748 deaths; HR, 1.00). Estimates for cancer incidence varied widely when stratified by whether participants reported supplement use before randomization, whereas estimates on mortality did not vary, except for CVD mortality. The findings provide evidence of long-term effects of CaD supplementation on mortality in postmenopausal women. Source: https://www.acpjournals.org/
Children and adolescents who regularly consume sugar-sweetened beverages (SSBs) and fruit juice may face a…
Women who consistently performed resistance training had a substantially lower risk of major cardiovascular disease…
US Adults with prediabetes who participated in an intensive lifestyle intervention had a significantly lower…
The impact of late-life high blood pressure (BP) on dementia risk appears to depend on…
A U.S. study found that receiving the recombinant herpes zoster vaccine (RZV, shingles vaccine) was…
A pooled analysis of 11 prospective cohort studies involving more than 1.5 million adults found…
This website uses cookies.